Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Anne Koelewijn

PhD student
Anne Koelewijn
Anne Koelewijn

Antibody-based treatment for Malignant Rhabdoid Tumors and Rhabdomyosarcoma

In December 2019, I joined the Janda group to start my PhD. My projects focus on developing antibody-based imaging and treatment strategies for children with Malignant Rhabdoid Tumors (MRTs) and Rhabdomyosarcoma (RMS) to increase their survival and quality of life. As part of my project, I leverage several techniques, including cell surface proteomics to unravel new cancer targets, the preparation of single-chain viable fragments (scFvs) and nanobodies that are specific for these targets and their functional characterization in cell-based assays.